Concentrum Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$936K Buy
3,829
+1,692
+79% +$394K 0.28% 41
2025
Q4
$442K Buy
2,137
+23
+1% +$4.55K 0.12% 56
2025
Q3
$392K Buy
2,114
+87
+4% +$14.9K 0.11% 53
2025
Q2
$310K Buy
2,027
+11
+0.5% +$1.69K 0.1% 58
2025
Q1
$334K Buy
2,016
+137
+7% +$21.4K 0.12% 59
2024
Q4
$272K Sell
1,879
-37
-2% -$5.73K 0.1% 70
2024
Q3
$310K Buy
1,916
+120
+7% +$19.1K 0.12% 56
2024
Q2
$263K Sell
1,796
-429
-19% -$63.8K 0.11% 59
2024
Q1
$352K Buy
2,225
+32
+1% +$5.09K 0.16% 51
2023
Q4
$344K Buy
2,193
+106
+5% +$16.3K 0.18% 49
2023
Q3
$325K Buy
2,087
+6
+0.3% +$990 0.2% 49
2023
Q2
$344K Sell
2,081
-63
-3% -$10.2K 0.22% 45
2023
Q1
$332K Buy
2,144
+11
+0.5% +$1.78K 0.25% 45
2022
Q4
$377K Buy
2,133
+9
+0.4% +$1.55K 0.34% 47
2022
Q3
$347K Buy
2,124
+10
+0.5% +$1.69K 0.3% 43
2022
Q2
$375K Buy
2,114
+10
+0.5% +$1.78K 0.31% 42
2022
Q1
$373K Buy
2,104
+9
+0.4% +$1.53K 0.23% 47
2021
Q4
$358K Buy
2,095
+376
+22% +$61.6K 0.19% 48
2021
Q3
$278K Buy
1,719
+9
+0.5% +$1.53K 0.17% 49
2021
Q2
$282K Buy
1,710
+9
+0.5% +$1.49K 0.18% 46
2021
Q1
$279K Sell
1,701
-297
-15% -$48.1K 0.21% 40
2020
Q4
$314K Buy
1,998
+12
+0.6% +$1.77K 0.25% 36
2020
Q3
$296K Buy
1,986
+12
+0.6% +$1.78K 0.28% 31
2020
Q2
$278K Buy
1,974
+311
+19% +$45.3K 0.28% 29
2020
Q1
$218K Buy
1,663
+10
+0.6% +$1.42K 0.29% 33
2019
Q4
$241K Buy
1,653
+9
+0.5% +$1.22K 0.27% 39
2019
Q3
$213K Buy
1,644
+7
+0.4% +$922 0.27% 40
2019
Q2
$228K Buy
1,637
+9
+0.6% +$1.25K 0.27% 38
2019
Q1
$228K Buy
1,628
+12
+0.7% +$1.61K 0.3% 31
2018
Q4
$209K Buy
+1,616
New +$225K 0.36% 25

Other funds holding JNJ

Concentrum Wealth Management's JNJ Position: Q1 2026 in Review

Concentrum Wealth Management increased its Johnson & Johnson (JNJ) stake by 79% in Q1 2026, buying an estimated $394K and bringing the position to 3,829 shares worth $936K. The position accounts for 0.28% of the portfolio, ranked #41.

Concentrum Wealth Management first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Concentrum Wealth Management held 3,829 shares of Johnson & Johnson worth $936K as of Q1 2026.
  • Concentrum Wealth Management bought 1,692 Johnson & Johnson shares in Q1 2026, an estimated $394K.
  • Johnson & Johnson made up 0.28% of Concentrum Wealth Management's portfolio in Q1 2026, its #41 holding.
  • Concentrum Wealth Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Concentrum Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.